| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/14/2004 | WO2004087864A2 Amended recombinant cells (arcs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants |
| 10/14/2004 | WO2004087767A1 Polypeptide |
| 10/14/2004 | WO2004087751A1 Dystrophin-related protein (drop1), a marker for carcinomas |
| 10/14/2004 | WO2004087748A1 Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same |
| 10/14/2004 | WO2004087747A2 Citrullinated synthetic peptides and uses thereof |
| 10/14/2004 | WO2004087744A2 Composition and method for nerve regeneration |
| 10/14/2004 | WO2004087743A2 Anti-hypertensive peptide derivatives and process for preparation thereof |
| 10/14/2004 | WO2004087741A1 Crystalline phases of a potent hcv inhibitor |
| 10/14/2004 | WO2004087740A2 Preserved and stable compositions containing peptide copper complexes and methods related thereto |
| 10/14/2004 | WO2004087736A2 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 10/14/2004 | WO2004087734A2 Stq-peptides |
| 10/14/2004 | WO2004087733A2 Prevention and treatment of alzheimer amyloid deposition |
| 10/14/2004 | WO2004087213A1 Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 10/14/2004 | WO2004087211A2 Inhibitors of phosphodiesterases in infertility |
| 10/14/2004 | WO2004087208A1 Thermotherapeutic for malignant tumor comprising heat shock protein and fine magnetic particles |
| 10/14/2004 | WO2004087206A2 Methods of treating diabetes by blocking vegf-mediated activity |
| 10/14/2004 | WO2004087199A1 Composition for improving insulin resistance |
| 10/14/2004 | WO2004087198A1 Use of coagulation proteins to lyse clots |
| 10/14/2004 | WO2004087197A1 Drug production process corresponding carrier and use |
| 10/14/2004 | WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 10/14/2004 | WO2004087194A2 Use of a dg931 protein for treating diabetes, obesity and metabolic syndrome |
| 10/14/2004 | WO2004087193A1 Use of a peptide that interacts with alpha v beta3 integrin of endothelial cell |
| 10/14/2004 | WO2004087192A1 Pharmaceutical and cosmetic compositions which are used to prevent and treat cell ageing through the sequestration of reactive carbonyl species |
| 10/14/2004 | WO2004087191A1 Composition for the prevention and treatment of cellulitis |
| 10/14/2004 | WO2004087190A1 Method for the treatment of prostate cancer |
| 10/14/2004 | WO2004087189A2 Use of bacteriocin for the amelioration of digestive functionality |
| 10/14/2004 | WO2004087188A1 Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
| 10/14/2004 | WO2004087119A2 Compositions containing superoxide dismutase and a selected et 5-lipoxygenase inhibitor and uses thereof |
| 10/14/2004 | WO2004087072A2 Topical l-carnitine compositions |
| 10/14/2004 | WO2004087071A2 Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection |
| 10/14/2004 | WO2004087067A2 Treatment of aspergillus infections with thymosin alpha 1 |
| 10/14/2004 | WO2004087065A2 Compositions for induction of a therapeutic response |
| 10/14/2004 | WO2004087063A2 Use of erythropoietin in stroke recovery |
| 10/14/2004 | WO2004087059A2 Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding |
| 10/14/2004 | WO2004087058A2 Targeted mhc class i alpha3 vaccine delivery systems |
| 10/14/2004 | WO2004087057A2 Methods for inhibition of angiogenesis |
| 10/14/2004 | WO2004087055A2 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 10/14/2004 | WO2004087054A2 Methods for modulating gastric secretion using prokineticin receptor antagonists. |
| 10/14/2004 | WO2004087046A2 TREATMENT OR PREVENTION OF cGMP-DEPENDENT PATHOPHYSIOLOGY WITH A MUTANT VARIANT OF SOLUBLE GUANYLYL CYCLASE |
| 10/14/2004 | WO2004072093A3 Antimicrobial agents from streptococcus mitis and streptococcus oralis |
| 10/14/2004 | WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 10/14/2004 | WO2004071392A8 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 10/14/2004 | WO2004060269A3 Mda-7 and free radicals in the treatment of cancer |
| 10/14/2004 | WO2004058186A3 Formulations for pulmonary delivery |
| 10/14/2004 | WO2004052914A8 Compositions and methods for inhibiting malaria protease falcipain-2 |
| 10/14/2004 | WO2004046182A3 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 10/14/2004 | WO2004045376A3 Screening methods to identify treatments for autoimmune disease |
| 10/14/2004 | WO2004044229A3 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 10/14/2004 | WO2004044192A3 Plasmodium protozoa phosphodiesterase, nucleic acid encoding the phosphodiesterase, and treatment of malaria using inhibitor of the phosphodiesterase |
| 10/14/2004 | WO2004044181A3 Antisense modulation of apolipoprotein b expression |
| 10/14/2004 | WO2004042402A3 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 10/14/2004 | WO2004042076A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) |
| 10/14/2004 | WO2004041303B1 Oral formulation or botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease |
| 10/14/2004 | WO2004041152A3 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
| 10/14/2004 | WO2004032827A3 Hepatitis c virus inhibitors |
| 10/14/2004 | WO2004031233A3 Novel chemokine-like polypeptides |
| 10/14/2004 | WO2004026118A3 Administration of free radical scavengers to prevent or treat ischemia-reperfusion injuries |
| 10/14/2004 | WO2004024875A8 Mammalian megakaryocyte progenitor cell |
| 10/14/2004 | WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor |
| 10/14/2004 | WO2004021010A3 Method of diagnosing colon and gastric cancers |
| 10/14/2004 | WO2004019866B1 Compositions and methods for treating cardiovascular disease |
| 10/14/2004 | WO2004017916A3 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 10/14/2004 | WO2004015067A3 Sperm-specific cation channel, catsper-3, and uses therefor |
| 10/14/2004 | WO2004011483A3 Isolated, ssx-2 and ssx-2 related peptides useful as hla binders and ctl epitopes, and uses thereof |
| 10/14/2004 | WO2004007679A3 Dendritic cell pontentiation |
| 10/14/2004 | WO2004004798A3 Central airway administration for systemic delivery of therapeutics |
| 10/14/2004 | WO2003104282A3 Glycoprotein vi - fc fusion protein for treating vascular disorders |
| 10/14/2004 | WO2003101395A3 Formulations for amylin agonist peptides |
| 10/14/2004 | WO2003091395A3 Inhibition of immune complex formation |
| 10/14/2004 | WO2003088921A3 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression |
| 10/14/2004 | WO2003087135A3 Novel pheromone receptor |
| 10/14/2004 | WO2003076642A3 Novel proteins and nucleic acids encoding same |
| 10/14/2004 | WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 10/14/2004 | WO2003065985A3 Uses of mammalian cytokine; related reagents |
| 10/14/2004 | WO2002064732A8 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL ALPHA-SUBUNIT, K+alphaM1, AND VARIANTS THEREOF |
| 10/14/2004 | WO2002030980A8 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 10/14/2004 | WO2001075067A8 Novel nucleic acids and polypeptides |
| 10/14/2004 | US20040205835 Jak kinases and regulation of cytokine signal transduction |
| 10/14/2004 | US20040205832 Transgenically produced decorin |
| 10/14/2004 | US20040204862 Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 10/14/2004 | US20040204673 Modular infusion device and method |
| 10/14/2004 | US20040204617 Solvent extraction to remove free radical of p-benzoquinone (p-benzosemiquinone) from cigarette; purification, crystallization and quantitative analysis |
| 10/14/2004 | US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 10/14/2004 | US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 10/14/2004 | US20040204578 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/14/2004 | US20040204574 TSA305 gene |
| 10/14/2004 | US20040204568 Comprises nucleotide sequences coding cell adhesion molecules for use in the diagnosis, prevention and treatment of autoimmune and cell proliferative disorders |
| 10/14/2004 | US20040204566 Chemically-modified G-CSF |
| 10/14/2004 | US20040204565 Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 10/14/2004 | US20040204564 CRFR1 selective ligands |
| 10/14/2004 | US20040204484 Therapeutic mixture useful in inhibiting lesion formation after vascular injury |
| 10/14/2004 | US20040204399 Aerosolized decongestants for the treatment of sinusitis |
| 10/14/2004 | US20040204393 Aromatase inhibition to enhance assisted reproduction |
| 10/14/2004 | US20040204390 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 10/14/2004 | US20040204379 Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
| 10/14/2004 | US20040204376 Focal calcium channel modulation |
| 10/14/2004 | US20040204373 compound of 8 to 50 nucleobases in length targeted to nucleic acid molecule encoding Histone deacetylase 1, where compound specifically hybridizes with and inhibits expression of Histone deacetylase 1; use in treating animal having disease or condition associated with Histone deacetylase 1 such as cancer |
| 10/14/2004 | US20040204368 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient |
| 10/14/2004 | US20040204367 Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis |
| 10/14/2004 | US20040204366 one effecting opioid analgesia and one effecting local anesthesia, in amounts sufficient to potentiate an antinociceptive response when both compounds are topically administered in a physiologically acceptable topical excipient |